MOLECULAR MECHANISMS OF ANTITUMOR EFFECTS OF HMG-CoA REDUCTASE INHIBITORS
Public support
Provider
Ministry of Health
Programme
Branch programm of research of the Ministry of Health
Call for proposals
VaV pro Ministerstvo zdravotnictví 1 (SMZ02004NR)
Main participants
—
Contest type
VS - Public tender
Contract ID
—
Alternative language
Project name in Czech
Molekulární mechanismy protinádorových účinků inhibitorů HMG-CoA reduktázy
Annotation in Czech
Studium mechanismů protinádorových účinků inhibitorů HMG-CoA reduktázy na experimentálním modelu adenokarcinomu pankreatu.
Scientific branches
R&D category
NV - Nonindustrial research (Applied research excluded Industrial research)
CEP classification - main branch
FD - Oncology and haematology
CEP - secondary branch
—
CEP - another secondary branch
—
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
30204 - Oncology<br>30205 - Hematology
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
Intensive research has proved its indisputable role in pathogenesis of particularly inflammatory and tumor disease and revealed many possibilities in the modulation of its function.
Solution timeline
Realization period - beginning
Jan 1, 2004
Realization period - end
Jan 1, 2006
Project status
U - Finished project
Latest support payment
—
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP07-MZ0-NR-U/06:2
Data delivery date
Aug 8, 2007
Finance
Total approved costs
2,500 thou. CZK
Public financial support
2,057 thou. CZK
Other public sources
321 thou. CZK
Non public and foreign sources
117 thou. CZK